Beauty and Wellness Consumers Flocking to Bevvy of New CBD Formulas and Products

New products containing the non-psychoactive cannabinoid CBD is boosting an already booming beauty industry. Consumer spending for the Total Beauty Market is projected to reach $758 billion in sales by 2024. But it’s the potential from the infusion of CBD products into the fold that is drawing in the efforts of several producers and retailers into the CBD beauty space, including The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF), Green Growth Brands (CSE:GGB) (OTC:GGBXF), Cronos Group Inc. (NASDAQ:CRON)(TSX:CRON), American Eagle Outfitters, Inc. (NYSE:AEO) and The Estée Lauder Companies Inc. (NYSE:EL).

Perhaps leading the way with some of the most innovative proprietary formulas and products is The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF), whose thriving line of products that includes the popular brands Urban Juve Wellness and Wright &Well, as well as other white-label agreements. To date, the company has acquired or developed more than 200 cannabis beauty, wellness, and beverage formulas for commercialization, and has signed C$3.7 million worth in agreements over the past 14 months.

The marriage of cannabinoids and cosmetics is already underway, with analysts at Piper Jaffray seeing a beauty boost to CBD sales potentially culminating in a $100 billion market. Even more conservative estimates such as one from research group Jefferies predicts the CBD Market alone will reach $25 billion in 10 years, while a study from Arcview Market Research and partners BDS Analytics pegged worldwide sales of legal cannabis to reach $57 billion by 2027.

Retailers and consumers alike can likely expect to see more products from The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF) in the months to come, while many of the company’s much larger competitors have recently gotten into the action.

Mall shoppers are already starting to see more Seventh Sense brand kiosks from Green Growth Brands (CSE:GGB) (OTC:GGBXF) that sell all types of CBD products in high-traffic mall locations. As well, GGB products are also being sold in American Eagle Outfitters, Inc. (NYSE:AEO) which is expected to launch a full beauty business prior to holiday season that will include CBD-infused lotions, muscle balms and aromatherapy products.

The move by AEO is expected to take a run at Sephora as a one-stop shop for teens. Sephora has already been carrying CBD products for months, starting with the Lord Jones brand—now owned by Cronos Group Inc. (NASDAQ:CRON)(TSX:CRON)— and more recently the CBD Calm face mask from Estée Lauder (NYSE:EL).

CBD BEAUTY: BEHIND THE SCENES

Before each product hits retailer shelves and lands in the consumers’ baskets, plenty of development, testing, and prep needs to be done. Perhaps one of the most prolific producers of these new cannabis beauty and wellness products is The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF).

As it continues to develop its product catalogue, Yield Growth currently has 26 new products in stability testing with an additional 13 products on deck due to begin testing in upcoming weeks.

“Stability testing is a crucial part of the production process. It guarantees that the formulation works as intended by providing a two-year shelf life. To ensure their efficacy, we use a minimum amount of clean, plant-based preservatives in all our products.” says Bhavna Solecki, Director of Product Development at Yield Growth. “In order to create these high-quality, natural products, Yield Growth invests a lot of time in research and development. R&D is a major facet of our operations, seeking to develop and enhance the existing products, while creating new formulations.”

Included in the licensing agreements announced and signed in the past 14 months were: a C$1 million 3-year exclusive Italian rights deal to distribute brands and infuse products with CBD and THC; a C$1 million agreement for US rights to infuse products with CBD and THC; a C$800,000 deal for international rights to products for a hemp-infused men’s line; and another C$900,000 for European rights deal to infuse formulas with CBD.

“We continue to negotiate more licensing and distribution agreements, and we plan on signing several new deals before year end,” said Penny White, CEO of Yield Growth. “Our continued development of our catalogue of hemp formulas for CBD and THC infusion supports our international licensing strategy.”

The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF) continues to development its catalogue with 26 new products in the process of stability testing at a laboratory in British Columbia, including: Six (6) essential oil perfumes, four (4) natural remedy blends with essential oils, foot cream and hand cream made with proprietary hemp root oil and exotic botanicals. The company has also developed eight (8) men’s products, including four essential oil colognes, shaving cream, hair balm, beard oil, and eight (8) white label versions of men’s products without hemp root oil.

The company’s products capitalize on the growing consumer trend to seek products with natural, pure ingredients. Many of Yield Growth’s beauty and wellness formulas contain hemp root oil made with the company’s patent-pending extraction technology, and are designed to be infused with cannabinoids, such as CBD and THC.
The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF) will participate in the upcoming Jefferies Fitness and Wellness Summit in New York.

MAINSTREAM CBD POTENTIAL

Growing popularity of the Urban Juve line from The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF) has spread to the benefit of other products in the space. Much of the Yield Growth’s team’s experience comes from mainstream global brands including Johnson & Johnson, Procter & Gamble, M·A·C Cosmetics, Skechers, Best Buy, Aritzia, Coca-Cola and Pepsi Corporation.

Now we’re seeing American Eagle Outfitters, Inc. (NYSE:AEO) get into the CBD beauty fray, selling a variety of CBD-infused products including those of Green Growth Brands (CSE:GGB) (OTC:GGBXF). A brick-and-mortar mall mainstay, AEO has launched its attempt to become a one-stop-shop for teens, that includes fashion, and beauty and wellness products.

GGB will also be aggressively rolling out more kiosks and stores for its Seventh Sense line of CBD products. In just the first seven months of the year, the company successfully opened more than 100 CBD shops in the United States.

Starting with its Calm face mask, Estée Lauder (NYSE:EL) began selling CBD products on the website of popular cosmetics retailer Sephora. The first CBD brand to launch on Sephora’s sales options was Lord Jones, which Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) acquired earlier this year. Cronos plans to capitalize with Lord Jones on a growing number of consumers clamoring for beauty products, foods and oils containing the cannabis compound in the fast-growing US CBD market.

Estée Lauder has since gone on to expand its Sephora CBD offerings to include CBD-infused lotions. There is likely even more to come from EL, given that Estée Lauder Labs were the first to present that cannabidiol has positive effects on eczema.

The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF) will likely be at the forefront of many of these new products, given its proprietary, patent-pending extraction technology that produces its Urban Juve Wellness hemp root oil.

Thanks to the way it’s produced, hemp root oil is one of the most compliant sources of CBD available, and Urban Juve is unique in its ability to produce it. Look for more CBD beauty and wellness products in the months to come.

Legal Disclaimer/Disclosure: While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our article is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. Furthermore, it is certainly possible for errors or omissions to take place regarding the profiled company, in communications, writing and/or editing. Nothing in this publication should be considered as personalized financial advice. We are not licensed under any securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this article is not provided to any individual with a view toward their individual circumstances. Baystreet.ca has been paid a fee of fifty thousand dollars for The Yield Growth Corp. advertising from the company. There may be 3rd parties who may have shares of The Yield Growth Corp. and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this article as the basis for any investment decision. The owner/operator of Baystreet.ca has purchased shares of The Yield Growth Corp. through a private placement and does not intend on selling any shares within 72 hours of this updated publication date after such point we reserve the right to buy and sell shares in the open market, no further notice will be given. By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing Baystreet.ca, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.